These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma.
    Author: Karatas F, Sahin S, Aytekin A, Hacioglu MB, Imamoglu GI, Altinbas M.
    Journal: J Cancer Res Ther; 2018; 14(5):1149-1151. PubMed ID: 30197367.
    Abstract:
    Due to the cytotoxic effects of old chemotherapy regimens used in the islet cell tumors, capecitabine plus temozolomide combination has now become the first choice in the treatment of malignant insulinoma (MIoma). We present this case to emphasize and remind that a durable complete response in advanced stage MIoma may be achieved with a short course of streptozotocin plus doxorubicin combination.
    [Abstract] [Full Text] [Related] [New Search]